ArticleClinical, cosmetic and investigational dermatology2024

Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study.

Fabrizio Martora et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.